Clinical Trials Logo

Cerebral Palsy, Dyskinetic clinical trials

View clinical trials related to Cerebral Palsy, Dyskinetic.

Filter by:
  • None
  • Page 1

NCT ID: NCT06036199 Recruiting - Secondary Dystonia Clinical Trials

Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects

Start date: January 26, 2024
Phase: N/A
Study type: Interventional

The primary objective of the proposed study is to evaluate the safety of ExAblate Transcranial MRgFUS as a tool for creating bilateral or unilateral lesions in the globus pallidus (GPi) in patients with treatment-refractory secondary dystonia due to dyskinetic cerebral palsy

NCT ID: NCT04395729 Recruiting - Clinical trials for Cerebral Palsy, Spastic

Functional Benefits of Multisite Surgery for the Upper Limb of Children With Cerebral Palsy

Start date: July 9, 2020
Phase:
Study type: Observational

The aim of the study is to investigate the impact of individualized multisite neuro-orthopedic surgery of the upper limb in children with Cerebral Palsy on unilateral functional capacities and bimanual performance. The investigators also assessed the attainment of individualized goals and tracked any potential factors that may have an impact on final results.

NCT ID: NCT04200352 Terminated - Clinical trials for Cerebral Palsy, Dyskinetic

A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy

Start date: February 4, 2020
Phase: Phase 3
Study type: Interventional

Study TV50717-CNS-30081 is a 55-week study in which participants who have successfully completed the parent study (Study TV50717-CNS-30080) may be eligible to enroll in this study. The primary objective of this study is to evaluate the safety and tolerability of long-term therapy with TEV-50717 in children and adolescents with DCP. The secondary objective of this study is to evaluate the efficacy of long-term therapy with TEV-50717 in reducing the severity of DCP.

NCT ID: NCT03813238 Completed - Clinical trials for Cerebral Palsy, Dyskinetic

A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents

RECLAIM-DCP
Start date: August 6, 2019
Phase: Phase 3
Study type: Interventional
Read more »